Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/56836| Title: | Do stAtins faVourably modify atherosclerotIc plaque in patients with differeNt levels of polygenic Cardiovascular (CV) rIsk? | Monash Health Investigator(s): | Nicholls S.J. | Registration Date: | 6-Nov-2020 | Monash Health Site(s): | Monash Medical Centre | Trial Phase: | Not Applicable | Summary: | This study will be a placebo-controlled, double-blind, randomised Phase 2b/3 study in participants with established cardiovascular disease to evaluate the impact of statin therapy on changes in plaque burden and composition in participants with different polygenic risk scores using CT coronary angiogram. The study will take place at ten sites in Australia. | Type: | Clinical trial | Registry ID: | ACTRN12620001166965 | URL: | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=380177 |
| Appears in Collections: | Clinical Trials |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
